Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natural Antioxidants in the Treatment of Multiple Sclerosis
NCT00010842Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Sep 1999
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2 trial of ginkgo biloba extract, alpha-lipoic acid, vitamin e and selenium in multiple sclerosis (MS) (3 arms), sponsored by National Center for Complementary and Integrative Health. Primary endpoint: Disease Activity detected with gadolinium-enhanced MRI. Started Sep 1999; status: completed.
02
Drugs
ginkgo biloba extractalpha-lipoic acidvitamin eselenium
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00010842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010842.